| 000 | 01885 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517181644.0 | ||
| 264 | 0 | _c20180502 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdx546 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCremolini, C | |
| 245 | 0 | 0 |
_aNegative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cDec 2017 |
||
| 300 |
_a3009-3014 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xenzymology |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrosatellite Instability |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aMorano, F | |
| 700 | 1 | _aMoretto, R | |
| 700 | 1 | _aBerenato, R | |
| 700 | 1 | _aTamborini, E | |
| 700 | 1 | _aPerrone, F | |
| 700 | 1 | _aRossini, D | |
| 700 | 1 | _aGloghini, A | |
| 700 | 1 | _aBusico, A | |
| 700 | 1 | _aZucchelli, G | |
| 700 | 1 | _aBaratelli, C | |
| 700 | 1 | _aTamburini, E | |
| 700 | 1 | _aTampellini, M | |
| 700 | 1 | _aSensi, E | |
| 700 | 1 | _aFucà, G | |
| 700 | 1 | _aVolpi, C | |
| 700 | 1 | _aMilione, M | |
| 700 | 1 | _aDi Maio, M | |
| 700 | 1 | _aFontanini, G | |
| 700 | 1 | _aDe Braud, F | |
| 700 | 1 | _aFalcone, A | |
| 700 | 1 | _aPietrantonio, F | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 12 _gp. 3009-3014 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdx546 _zAvailable from publisher's website |
| 999 |
_c27698025 _d27698025 |
||